🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2005-11
Trial ID
NCT00265850
Treatments Being Tested
This clinical program aims to evaluate the activity and efficacy of cetuxim...
Status
Active Not Recruiting
Location
A.O.U. Ospedali Riuniti
Start Date
2021-07-15
Trial ID
NCT05312398
Treatments Being Tested
This phase III trial compares hepatic arterial infusion (HAI) (pump chemoth...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-10-19
Trial ID
NCT05863195
This clinical trial evaluates the efficacy and safety of adding fecal micro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07509398
Treatments Being Tested
This open-label single arm study will evaluate the efficacy and safety of A...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01077739
Treatments Being Tested
The purpose of this study is to determine the putative recommended phase 2 ...
Status
Recruiting
Location
University of Arizona Cancer Center
Start Date
2024-10-15
Trial ID
NCT06663319
Treatments Being Tested
Immune chekpoints (ICI) are evaluated in many digestive cancers. Certain ty...
Status
Completed
Location
Ch - Centre Hospitalier D'Abbeville
Start Date
2018-04-24
Trial ID
NCT03186326
Treatments Being Tested
The aim of this trial is to assess the feasibility of EREG/AREG assessment ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-15
Trial ID
NCT07094893
The goal of this Phase 3 clinical trial is to evaluate whether continuing c...
Status
Recruiting
Location
A.O.U. Ospedali Riuniti
Start Date
2025-10-01
Trial ID
NCT07389265
Microdevices have been used to ascertain in vivo drug response, which can l...
Status
Recruiting
Location
RJ Zuckerberg
Start Date
2025-12-10
Trial ID
NCT07193862
Treatments Being Tested